All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: HBV-HIV Coinfection-30257068

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	30257068	D144A	S	S	HBV-HIV Coinfection	G C L	View
2	30257068	F212C	S	S	HBV-HIV Coinfection	G C L	View
3	30257068	G185L	S	S	HBV-HIV Coinfection	G C L	View
4	30257068	N207T	S	S	HBV-HIV Coinfection	G C L	View
5	30257068	P178Q	S	S	HBV-HIV Coinfection	G C L	View
6	30257068	P203Q	S	S	HBV-HIV Coinfection	G C L	View
7	30257068	P203R	S	S	HBV-HIV Coinfection	G C L	View
8	30257068	S140L	S	S	HBV-HIV Coinfection	G C L	View
9	30257068	S167L	S	S	HBV-HIV Coinfection	G C L	View
10	30257068	S174N	S	S	HBV-HIV Coinfection	G C L	View
11	30257068	S204G	S	S	HBV-HIV Coinfection	G C L	View
12	30257068	S204I	S	S	HBV-HIV Coinfection	G C L	View
13	30257068	S204K	S	S	HBV-HIV Coinfection	G C L	View
14	30257068	S204N	S	S	HBV-HIV Coinfection	G C L	View
15	30257068	S204R	S	S	HBV-HIV Coinfection	G C L	View
16	30257068	S204T	S	S	HBV-HIV Coinfection	G C L	View
17	30257068	V224A	S	S	HBV-HIV Coinfection	G C L	View
18	30257068	V224Y	S	S	HBV-HIV Coinfection	G C L	View
19	30257068	W191L	S	S	HBV-HIV Coinfection	G C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.